ArticleBMC cancer2020

Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer.

Mashiro Okunaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.